Item 9 Labs Corp. (INLB) has a market capitalization of $70.18K and trades at $0.00. The 52-week range is 0.0001-0.0001.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.33, annual revenue of $21.76M.
The stock has a beta of 0.07, operates in the Healthcare sector.
